Guys, it really comes down to the work involved with submitting the applications not how large or small the country is. And quite frankly, if the FDA approves it, Australia will approve it based on that as well. So do the large potentials first, and let the smaller ones come behind. You don’t need your top-tier talent who is chartered with getting the applications completed, and the drug approved wasting their time on smaller potentials upfront.
Market Data 
Markets 
AI
